Home › Funds › Keenan, LLC › TAK

Keenan, LLC position in TAK

TAKEDA PHARMACEUTICAL CO LTD · Health Care

Keenan, LLC reported holding 17,513 shares of TAK (TAKEDA PHARMACEUTICAL CO LTD) in its Q3 2026 13F filing — a position valued at US$319K, representing 0.22% of its reported portfolio and ranking #35 among its reported holdings. Keenan, LLC has disclosed TAK holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)17.51K sh
Reported value held$318.56K
Portfolio Weight0.22%
First reportedQ4 2025
Last changeHold
Updated2026-10-23

Last updated: 2026-10-23 · Source: SEC EDGAR Form 13F-HR

How Keenan, LLC's TAK position evolved

Keenan, LLC first disclosed a stake in TAK in Q4 2025 at 17,513 shares (US$273K). The position peaked in Q1 2026 at 17,513 shares, worth US$324K. Across 4 filings, Keenan, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 17,513 shares valued at US$319K.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 17.51K $273.03K New
Q1 2026 17.51K $324.34K Hold
Q2 2026 17.51K $280.73K Hold
Q3 2026 17.51K $318.56K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TAK and 13F data

TAK (TAKEDA PHARMACEUTICAL CO LTD) is a Health Care company. 31 other funds we track also report a position in TAK — the largest reported positions include MANAGED ASSET PORTFOLIOS, LLC (US$29.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TAK

All TAK fund holders →

FAQ

How long has Keenan, LLC held TAK?

Keenan, LLC has disclosed TAK holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Keenan, LLC's current position in TAK?

As of Q3 2026, Keenan, LLC holds 17.51K shares of TAK (TAKEDA PHARMACEUTICAL CO LTD), valued at $318.56K, representing 0.22% of its reported portfolio and ranking #35.

Has Keenan, LLC been buying or selling TAK?

In the latest 13F filing (Q3 2026), Keenan, LLC held unchanged its position in TAK. The position peaked in Q1 2026 at 17.51K shares.

Which other funds hold TAK?

Other major institutional holders of TAK include MANAGED ASSET PORTFOLIOS, LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.